Publication | Closed Access

Mesangial AT<SUB>1</SUB>/B<SUB>2</SUB> Receptor Heterodimers Contribute to Angiotensin II Hyperresponsiveness in Experimental Hypertension

Molecular PharmacologyHypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyPhysiologyAngiotensin Ii HyperresponsivenessCardiovascular PharmacologyVascular PharmacologyCardiovascular ReactivityEndocrine HypertensionPharmacologyMesangial AtBlood PressureExperimental Hypertension